HSBC Holdings’s iHuman IH Stock Holding History

HSBC Holdings’s Portfolio IH Stock Details IH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-28,722	Closed	-$136K	–	3296
2021 Q3	$136K	Sell	28,722 -1,121	-4%	-$8.35K	﹤0.01%	2848
2021 Q2	$306K	Buy	29,843 +1,121	+4%	+$12.4K	﹤0.01%	2503
2021 Q1	$358K	Buy	+28,722	New	+$507K	﹤0.01%	2193

Other funds holding IH

APA

Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HSBC Holdings's IH Position: Q4 2021 in Review

HSBC Holdings sold out of iHuman (IH) in Q4 2021, closing a stake of 28,722 shares — an estimated $136K sold.

HSBC Holdings first reported a position in IH in Q1 2021 and held it in 3 quarters. The position peaked at $358K in Q1 2021. 8 funds tracked by Wall St. Rank hold IH as of Q4 2021.

HSBC Holdings reported no remaining iHuman position as of Q4 2021 after selling out during the quarter.
HSBC Holdings sold 28,722 iHuman shares in Q4 2021, an estimated $136K.
HSBC Holdings first reported a position in iHuman in Q1 2021 and held it in 3 quarters.
HSBC Holdings's iHuman position peaked at $358K in Q1 2021.
8 funds tracked by Wall St. Rank held iHuman as of Q4 2021.

Based on HSBC Holdings's 13F filing for Q4 2021, filed 11 Feb 2022.